Peri-implantitis is a site-specific infectious disease that causes an inflammatory process in soft tissues, and bone loss around an osseointegrated implant in function. Treatment will differ depending upon whether it is a case of peri-implant mucositis or peri-implantitis.
The global Peri-implantitis market is expected to enlarge at a considerable rate in the forecast period. Important factors such as the increasing number of dental procedures, the rising number of oral diseases, and the growth of the elderly population with tooth loss have boosted the growth of the global peri-implantitis market. As well, dental implants have become recognized therapy in dentistry essential to replace missing teeth in different clinical situations. The success rate of dental implants is reported to be around 82.9% after 16 years of follow-up. However, 10%–50% of the dental implants exhibited signs of peri-implantitis after 10 years. In addition to this, According to NCBI, in the U.S. from 1999 to 2017, per year 14.0% increase in implant prevalence was recorded. Annually there are about 2,60,000 implants placed in the U.K., which indicates the growing demand for dental implants.
Additionally, the arrival of technological advancement relating to the efficient treatment of peri-implantitis, and a rise in the patient population prone to smoking and diabetes are expected to fuel the market’s growth in the coming years.
On the downside, the high cost of dental procedures and lack of awareness are factors that hamper the growth of the peri-implantitis market in developing countries.
Covid-19 Impact on Peri-implantitis Market:
In addition, the current Peri-implantitis Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Peri-implantitis Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Peri-implantitis Market Segment Overview
Based on treatment, the surgical treatment segment is expected to increase at a high growth rate during the forecast period, as it is the most preferred option for the treatment of peri-implantitis. Additionally, the Laser debridement non-surgical technique is projected to witness the highest growth over the forecast period as it has improved clinical outcomes is efficient due to selective calculus removal.
Peri-implantitis Market, By Treatment
- Surgical
- Bone Regeneration
- Open Flap Debridement
- Implantoplasty
- Non-surgical
- Mechanical Debridement
- Laser Debridement
- Antibiotics
- Others
In terms of region, Europe is expected to be a dominant peri-implantitis market during the forecast period, followed by North America. Important factors such as increasing incidences of peri-implantitis, rising old age population, the surge in the number of dental issues and oral diseases, well-established health care infrastructure, and favorable reimbursement policies are driving the growth of the market in Europe. Similarly, the Asia Pacific is expected to register the fastest growth during the forecast period. Countries such as India and China contain large populations, favorable government initiatives, and the availability of developed health care facilities. This key fact majorly contributes to the market’s development in this region.
Peri-implantitis Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Peri-implantitis Market, Key Players
· Geistlich Pharma Inc.
· Aetna Inc.
· Dawood & Tanner
· Neoss
· Pfizer Inc.
· Cadila Pharmaceuticals
· R.N. Laboratories Pvt. Ltd.
· Basic Pharma Life Science Pvt. Ltd.
· Prachi Pharmaceuticals Private Limited.
· Healthy Life Pharma
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Peri-implantitis Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Treatment
- 5.2.1. Surgical
- 5.2.1.1. Bone Regeneration
- 5.2.1.2. Open Flap Debridement
- 5.2.1.3. Implantoplasty
- 5.2.2. Non-surgical
- 5.2.2.1. Mechanical Debridement
- 5.2.2.2. Laser Debridement
- 5.2.2.3. Antibiotics
- 5.2.2.4. Others
- 5.2.1. Surgical
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. Latin America, Middle East and Africa
6. North America Peri-implantitis Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Treatment
- 6.2.1. Surgical
- 6.2.1.1. Bone Regeneration
- 6.2.1.2. Open Flap Debridement
- 6.2.1.3. Implantoplasty
- 6.2.2. Non-surgical
- 6.2.2.1. Mechanical Debridement
- 6.2.2.2. Laser Debridement
- 6.2.2.3. Antibiotics
- 6.2.2.4. Others
- 6.2.1. Surgical
- 6.3.1. U.S.
- 6.3.2. Canada
7. Europe Peri-implantitis Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Treatment
- 7.2.1. Surgical
- 7.2.1.1. Bone Regeneration
- 7.2.1.2. Open Flap Debridement
- 7.2.1.3. Implantoplasty
- 7.2.2. Non-surgical
- 7.2.2.1. Mechanical Debridement
- 7.2.2.2. Laser Debridement
- 7.2.2.3. Antibiotics
- 7.2.2.4. Others
- 7.2.1. Surgical
- 7.3.1. UK
- 7.3.2. Germany
- 7.3.3. France
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Rest of Europe
8. Asia Pacific Peri-implantitis Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Treatment
- 8.2.1. Surgical
- 8.2.1.1. Bone Regeneration
- 8.2.1.2. Open Flap Debridement
- 8.2.1.3. Implantoplasty
- 8.2.2. Non-surgical
- 8.2.2.1. Mechanical Debridement
- 8.2.2.2. Laser Debridement
- 8.2.2.3. Antibiotics
- 8.2.2.4. Others
- 8.2.1. Surgical
- 8.3.1. China
- 8.3.2. India
- 8.3.3. Japan
- 8.3.4. Australia
- 8.3.5. South East Asia
- 8.3.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Peri-implantitis Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Treatment
- 9.2.1. Surgical
- 9.2.1.1. Bone Regeneration
- 9.2.1.2. Open Flap Debridement
- 9.2.1.3. Implantoplasty
- 9.2.2. Non-surgical
- 9.2.2.1. Mechanical Debridement
- 9.2.2.2. Laser Debridement
- 9.2.2.3. Antibiotics
- 9.2.2.4. Others
- 9.2.1. Surgical
- 9.3.1. Brazil
- 9.3.2. Saudi Arabia
- 9.3.3. UAE
- 9.3.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Geistlich Pharma Inc.
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Aetna Inc.
- 10.6. Dawood & Tanner
- 10.7. Neoss
- 10.8. Pfizer Inc.
- 10.9. Cadila Pharmaceuticals
- 10.10. R.N. Laboratories Pvt. Ltd.
- 10.11. Basic Pharma Life Science Pvt. Ltd.
- 10.12. Prachi Pharmaceuticals Private Limited.
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
